From progression to complete remission – a case study of successful pemigatinib treatment in a patient with metastatic FGFR2+ cholangiocarcinoma
Klinicka onkologie · 15.06.2026 · 39 (3) · 195-198
DOI: 10.48095/ccko2026195 ↗Kurz gefasst
Fallbericht in der Zeitschrift Klinicka onkologie, online erschienen am 15.06.2026. Verfasst von Bohuňovská Kateřina. Hauptthemen laut MEDLINE: Cholangiocarcinoma, Pyrimidines, Receptor, Fibroblast Growth Factor, Type 2, Bile Duct Neoplasms.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Zitieren
APA
Kateřina, B. (2026). From progression to complete remission – a case study of successful pemigatinib treatment in a patient with metastatic FGFR2+ cholangiocarcinoma. Klinicka onkologie, 39(3), 195-198. https://doi.org/10.48095/ccko2026195
Vancouver
Kateřina B. From progression to complete remission – a case study of successful pemigatinib treatment in a patient with metastatic FGFR2+ cholangiocarcinoma. Klinicka onkologie. 2026;39(3):195-198. doi:10.48095/ccko2026195
BibTeX
@article{Kateina2026,
author = {Kateřina, Bohuňovská},
title = {From progression to complete remission – a case study of successful pemigatinib treatment in a patient with metastatic FGFR2+ cholangiocarcinoma},
journal = {Klinicka onkologie},
year = {2026},
volume = {39},
number = {3},
pages = {195--198},
doi = {10.48095/ccko2026195}
}
EUVIMED